Breast Implants Market

Global Breast Implants Market Size (2023 to 2028)

The global breast implants market size is forecasted to be worth USD 1.96 billion in 2023 and USD 2.53 billion by 2028, growing at a CAGR of 5.20% during the forecast period.

Breast implants are made of silicone gels and are planted under the breasts through breast augmentation surgeries meant to help change the breasts' size, shape, and texture. Breast implants can be opted for by women above the age of 22 and are generally expensive and can cost anywhere from USD 6000 to USD 12000. There are multiple reasons why women can opt for a breast augmentation, like damage to the breast tissue or external traumatic impact, which is corrected by surgery, another reason can be to correct or redo a previously performed procedure, and the last reason can be for aesthetic appeal and improvement. Breast implants are considered relatively safe and have a natural skin-like texture. Often breast implants are opted for by small-chested women due to insecurities are society's standards of beauty. Women prefer them to feel comfortable and more confident in their bodies. The cases of body dysmorphia have been on the rise recently and are more common in teens, especially women, further prompting the growth of this market. There are mainly two types of breast implants preferred by people, saline breast implants and silicone breast implants, and they are used based on individual preference and suiting. 

MARKET DRIVERS:

The growth of the global breast implants market is primarily driven by the rising preference for better aesthetic appearance among women and the growing cases of psychological burden due to external appearance.

Breast implants can help women feel more confident in their skin and overcome certain insecurities which can harm their overall personality. In addition, the growing number of breast cancer cases is also propelling the market's rise. Breast cancer procedures often lead to women undergoing a mastectomy, after which they may seek breast implants to better their figure. The rising cases of breast cancer are supporting the rise of the market. For instance, according to World Health Organization (WHO), 685000 people worldwide died in 2020 due to breast cancer, which affected 2.3 million women. The most common cancer globally as of the end of 2020 was breast cancer, diagnosed in 7.8 million women in the previous five years. 

The growing popularity of breast augmentation surgery supports market growth.

The popularity of breast augmentation is on the rise due to several women worldwide preferring the alteration of their breasts. There are several reasons for this increased popularity. First, breast implants are incredibly safe and fast, and the patients do not need to take long vacations to recover. The saline and silicone implants are incredibly safe for the body. Even if the saline implants burst inside the body, the muscles will absorb the liquid with no side effects, and silicone implants are made, so they do not burst inside the body.

Additionally, the procedures only take 1-3 hours, and they recover completely within weeks. Therefore, the procedures are long-lasting and do not require frequent doctor visits after a few months. Furthermore, the rising customer satisfaction with the results is expected to boost the market. 

The several advantages of breast implants further augment the growth of the market.

Breast implants have several advantages; they boost the psychological morale of women and can help counter body dysmorphia. However, women with smaller chests often suffer from micromastia, which means abnormally tiny chests. Additionally, there are several conditions in which women have the extreme left and right breasts. Several bodily conditions may push women toward breast implants. For example, losing weight can lead to saggy breasts, and women prefer implants to get a firm structure; pregnant women often face problems with breast size, especially after and before lactation. Additionally, women with breast cancer who go through mastectomy and women who have faced some trauma or accident around the breasts opt for implants to gain self-confidence. 

The growing number of breast implant procedures supports the market expansion.

The rising satisfaction with procedures and rising interest in plastic surgeries, especially during the pandemic, is driving the market's rise. The growing interest in plastic surgeries and procedures, including breast augmentation, will propel market growth. Breast augmentation was one of the top surgical procedures of 2021, and the trend is expected to continue during the forecast period. For instance, in 2021, 365,000 breast augmentations were carried out. In addition, 71,000 women had their implants removed but not replaced, whereas 148,000 women had their implants removed and replaced.

MARKET RESTRAINTS:

Though there is rising popularity and several advantages to breast implants, there are also several disadvantages. Breast implant operation can lead to several complications like scars, loss of breast tissues, change in nipple sensation, pain, and implant rupture. Several patients have also reported side effects like brain fog, muscle fatigue, and body pains categorized as breast implant illness (BIL). In addition, breast implants are not permanent; the longer you have them inside, the more chance you'll have of side effects. They also require a regular diagnosis to avoid complications from ruptures like breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), cancer-related to implants. Often the patient may require surgery for the removal of breast implants, and it is essential to consider all the safety guidelines and consequences before opting for implants.

Impact of COVID-19 on the global breast implants market:

The COVID-19 pandemic took the whole world by surprise and led to an economic decline in the growth of markets worldwide. The breast implants market also faced significant losses during the forecast period due to the focus of the healthcare systems shifting completely toward covid care and all other procedures being postponed. Breast augmentation procedures were not considered a priority, and therefore all procedures relating to the same were postponed. However, the market is expected to bounce back from the losses in the post-pandemic era due to the increased interest in aesthetic appeal, including breast implants in women during the pandemic.

REPORT COVERAGE:

This research report on the global breast implants market has been segmented and sub-segmented based on Product type, Shape, Application, End-use, and Region

Global Breast Implants Market – By Product:

• Silicone Breast Implants
• Saline Breast Implants

Based on the product, the silicone breast implants segment dominated the market in 2022. This segment dominance is due to silicone's texture being very similar to actual breast tissue and the soft feel of the material. In addition, there is also less chance of scar tissue forming after the operation, further supporting the segment's revenue.

However, the saline breast implant segment is also expected to show significant growth during the forecast period due to its advantages over silicone implants, like the low need for frequent clinic visits and the fact it is entirely safe for it to burst inside the body as it is easily absorbed. 

Global Breast Implants Market – By Shape:

• Anatomical
• Round

Based on shape, the round-shaped implants segment is expected to lead the market during the forecast period due to the ideal appearance it creates after surgery. In addition, round implants are easier to handle and do not cause complications. 

However, the anatomical shape implant, designed to look more natural, is also becoming more popular as people looking for a non-artificial look tend to choose the shape. However, the anatomical shape has a higher risk of flipping, leading to a minor setback for the segment. 

Global Breast Implants Market – By Application:

• Cosmetic surgery
• Reconstructive surgery

The cosmetic surgery segment is expected to dominate the market during the forecast period due to the growing preference for cosmetic procedures to shelter the aesthetic appearance of breasts. In addition, women love breast implants related cosmetic surgeries as they give the look and feel of a natural breast. Furthermore, the FDA recently approved silicone implants, another thing supporting the segment's growth.

However, the reconstruction surgery segment is also expected to show significant growth as it aims to help women who need the resizing and appearance of their breasts, which can often happen due to various reasons. In addition, any breast trauma can result in a change of appearance, and the reconstruction procedures help restore the breasts to their previous appearance, further promoting the market growth.

Global Breast Implants Market – By End-User:

• Cosmetology Clinics
• Hospitals
• Ambulatory Surgical Centers

The hospital's segment is expected to dominate the market during the forecast period due to the rising popularity of plastic surgeons and procedures performed in certified hospital settings.

However, the cosmetology clinics segment is also expected to show significant growth due to the increasing trust in individual clinical performing procedures like breast augmentation and reconstruction, which are procedures approved by the U.S. FDA.

Global Breast Implants Market – By Region:

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

The breast implants market in North America had the major share of the global market in 2022 and is expected to hold the largest share of the market during the forecast period owing to the increasing healthcare costs in the United States, the expansion of breast augmentation procedures, the creation and marketing of new goods, favorable health insurance coverage for breast reconstruction, the growth in cosmetic procedures, an increase in product approvals from regulatory agencies, an increase in breast cancer incidence, the existence of prominent manufacturers, an increase in the burden of older women populace, and the introduction of awareness campaigns by many prominent market participants in the region. These several factors drive market growth for the region.

The European breast implant market is expected to grow at a noteworthy CAGR during the forecast period.

The breast implants market in the Asia-Pacific region is also expected to show significant progress in the market due to several factors, increasing demand for cosmetic operations, a propensity for silicone implants, increasing disposable income in developing nations, a choice of low-cost treatment options, government efforts to educate the populace, and a growth in breast augmentation procedures in nations like China and India supporting the rise of the market.

The Latin American breast implant market is growing due to the rising need for better healthcare infrastructures and increasing interest in cosmetic procedures, especially in countries like Brazil. 

KEY MARKET PLAYERS:

AbbVie Inc. (Allergan plc), Establishment Labs SA, GC Aesthetics, Groupe Sebbin SAS, Laboratories Arion, Johnson & Johnson (Mentor Worldwide LLC), Polytech Health & Aesthetics GmbH, Silimed, Sientra Inc., and Celaplas are some of the noteworthy companies in the global breast implants market.

RECENT HAPPENINGS IN THIS MARKET:

• In December 2022, for decades, Nicola Osypka's German business has supplied Europe with surgical tools used on newborn infants, but new EU regulations have made her face difficult choices. Companies must apply for fresh medical equipment certifications under restrictions intended to avert health scandals like the one in 2010 involving burst breast implants produced by Poly Implant Prothese.
• In December 2022, the United Arab Emirates Ministry of Health and Prevention gave Sientra, Inc. permission to market its line of smooth surface, High-Strength Cohesive (HSC and HSC+) silicone gel breast implants in the country. Sientra, Inc. is a medical aesthetics business dedicated to improving lives through the advancement of plastic surgery. With this latest permission, Sientra has expanded internationally three times this year.
• In December 2022, A class action lawsuit for alleged securities fraud against Allergan PLC was rejected by Judge Colleen McMahon. The plaintiffs failed to provide any proof, the court said, that Allergan intentionally deceived the public about a possible connection between some of their breast implants and a rare type of cancer, leading to the subsequent recall of those implants from the European market.
• In December 2022, FDA approved MedCognetics for breast cancer screening. Many artificial intelligence developers are creating algorithms that can find breast cancer as early as possible, when it's still quite curable, to combat the rising incidence of the disease. Many have already acquired FDA approval for their efforts, most recently MedCognetics.